LIGAND PHARMACEUTICALS INC - Common Stock (LGND) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
LGND on Nasdaq
Shares outstanding
19,667,509
Price per share
$189.07
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
20,501,758
Total reported value
$3,631,325,697
% of total 13F portfolios
0.01%
Share change
+1,415,864
Value change
+$253,382,275
Number of holders
308
Price from insider filings
$189.07
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14% -6.9% $502,945,206 -$18,898,723 2,839,251 -3.6% BlackRock, Inc. 30 Sep 2025
JANUS HENDERSON GROUP PLC 5.3% -3.3% $184,646,839 -$3,251,582 1,042,378 -1.7% JANUS HENDERSON GROUP PLC 30 Sep 2025

As of 30 Sep 2025, 308 institutional investors reported holding 20,501,758 shares of LIGAND PHARMACEUTICALS INC - Common Stock (LGND). This represents 104% of the company’s total 19,667,509 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) together control 77% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 2,884,527 -1% 0.01% $510,965,112
VANGUARD GROUP INC 11% 2,076,283 -0.63% 0.01% $367,792,771
JANUS HENDERSON GROUP PLC 5.3% 1,042,378 -1.7% 0.08% $184,646,169
MACQUARIE GROUP LTD 3.8% 751,788 -19% 0.16% $133,172,000
STATE STREET CORP 3.8% 749,360 -0.05% 0% $132,741,630
CONGRESS ASSET MANAGEMENT CO 3.4% 667,311 +3% 0.79% $118,207,471
Chicago Capital, LLC 2.9% 568,611 -0.56% 2.5% $100,723,721
Stephens Investment Management Group LLC 2.8% 554,542 -8.3% 1.3% $98,231,570
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.8% 541,845 +59% 0.03% $95,982,423
DIMENSIONAL FUND ADVISORS LP 2.7% 523,913 -26% 0.02% $92,798,928
GEODE CAPITAL MANAGEMENT, LLC 2.4% 474,189 -3% 0.01% $84,010,101
FMR LLC 2.3% 457,231 +1644% 0% $80,993,848
LOOMIS SAYLES & CO L P 2% 400,553 -2.5% 0.08% $70,953,958
Invesco Ltd. 1.9% 378,295 +65% 0.01% $67,011,177
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 1.9% 376,601 -3.9% 0.01% $66,711,102
GOLDMAN SACHS GROUP INC 1.9% 367,795 +477% 0.01% $65,151,206
DEUTSCHE BANK AG\ 1.6% 307,532 -0.09% 0.02% $54,476,219
RICE HALL JAMES & ASSOCIATES, LLC 1.5% 294,490 -13% 2.8% $52,165,870
VILLERE ST DENIS J & CO LLC 1.4% 279,950 -2.5% 4.8% $49,590,343
Ranger Investment Management, L.P. 1.4% 275,340 -8.2% 3.4% $48,773,728
NORTHERN TRUST CORP 1.4% 265,962 -3.9% 0.01% $47,112,509
VICTORY CAPITAL MANAGEMENT INC 1.3% 254,805 +677% 0.03% $45,136,158
ASHFORD CAPITAL MANAGEMENT INC 1.2% 244,430 -19% 4.8% $43,298,330
FRANKLIN RESOURCES INC 1.2% 229,856 +24% 0.01% $40,716,692
Private Capital Management, LLC 1.2% 227,158 -0.91% 3.7% $40,238,768

Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,317,145 $249,244,120 -$64,337,943 $189.07 39
2025 Q3 20,501,758 $3,631,325,697 +$253,382,275 $177.14 308
2025 Q2 19,192,413 $2,181,890,222 +$57,089,230 $113.68 269
2025 Q1 18,675,038 $1,966,143,201 +$46,469,596 $105.14 256
2024 Q4 18,232,299 $1,953,596,510 +$20,744,868 $107.15 254
2024 Q3 18,050,135 $1,806,360,430 +$73,339,806 $100.09 238
2024 Q2 17,255,101 $1,453,801,262 +$88,043,421 $84.26 230
2024 Q1 16,406,954 $1,199,130,993 +$23,482,568 $73.10 220
2023 Q4 11,106 $794,997 +$5,357 $71.63 2
2023 Q3 15,634,585 $936,945,355 +$5,471,334 $59.92 191
2023 Q2 15,313,188 $1,104,185,386 +$33,028,321 $72.10 199
2023 Q1 14,778,345 $1,086,750,384 +$25,176,279 $73.56 206
2022 Q4 14,546,768 $972,041,596 -$14,728,157 $66.80 189
2022 Q3 13,934,729 $1,200,012,662 -$2,610,799 $86.11 191
2022 Q2 14,926,337 $1,326,701,018 -$64,862,909 $89.22 181
2022 Q1 15,584,398 $1,752,954,025 -$90,361,562 $112.49 187
2021 Q4 16,247,950 $2,509,049,094 -$20,621,217 $154.46 210
2021 Q3 16,399,686 $2,285,148,890 +$68,600,397 $139.32 200
2021 Q2 15,926,490 $2,088,237,132 +$57,091,722 $131.19 208
2021 Q1 15,409,995 $2,349,025,770 -$955,818,664 $152.45 217
2020 Q4 22,353,097 $2,223,101,505 -$5,882,562 $99.45 226
2020 Q3 22,696,726 $2,163,122,008 +$67,257,423 $95.32 245
2020 Q2 22,040,895 $2,466,046,768 -$51,378,592 $111.85 250
2020 Q1 22,783,535 $1,656,828,613 -$15,121,173 $72.72 248
2019 Q4 22,453,380 $2,341,742,087 -$63,504,129 $104.29 250
2019 Q3 23,207,173 $2,310,118,632 -$159,332,310 $99.54 261
2019 Q2 24,598,482 $2,807,882,937 -$39,321,793 $114.15 291
2019 Q1 25,415,457 $3,195,106,879 -$112,344,803 $125.71 314
2018 Q4 26,738,214 $3,627,706,738 +$255,710,799 $135.70 345
2018 Q3 24,240,672 $6,643,850,885 -$318,288,457 $274.49 369
2018 Q2 25,456,899 $5,273,076,711 +$237,576,127 $207.17 336
2018 Q1 24,263,677 $3,995,102,214 +$70,539,454 $165.16 317
2017 Q4 24,661,077 $3,377,943,330 -$25,150,866 $136.93 292
2017 Q3 24,592,670 $3,349,074,589 -$39,913,004 $136.15 284
2017 Q2 24,506,261 $2,974,570,121 +$95,393,215 $121.40 257
2017 Q1 24,599,561 $2,603,722,126 +$242,017,280 $105.84 246
2016 Q4 24,764,031 $2,516,496,895 +$4,613,713 $101.61 262
2016 Q3 24,275,125 $2,475,584,361 +$61,576,257 $102.06 253
2016 Q2 24,655,240 $2,940,270,320 -$22,676,475 $119.27 260
2016 Q1 24,225,518 $2,595,796,783 +$161,341,468 $107.09 243
2015 Q4 23,158,550 $2,510,508,368 +$42,986,493 $108.42 230
2015 Q3 22,765,236 $1,949,833,985 -$32,271,815 $85.65 200
2015 Q2 21,333,846 $2,152,568,586 -$50,889,812 $100.90 211
2015 Q1 21,977,564 $1,694,671,185 +$80,108,927 $77.11 180
2014 Q4 21,573,191 $1,147,818,317 -$776,639 $53.21 177
2014 Q3 21,646,891 $1,017,048,713 +$40,549,323 $46.99 172
2014 Q2 20,071,933 $1,250,273,088 -$48,358 $62.29 189
2014 Q1 20,820,041 $1,400,557,580 +$25,752,122 $67.26 181